Duchenne/Becker muscular dystrophy: From molecular diagnosis to gene therapy

Brain and Development

Volumn 18, Issue 3, 1996, Pages 167-172

  Matsuo, Masafumi ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DYSTROPHIN; MESSENGER RNA;

BECKER MUSCULAR DYSTROPHY; DUCHENNE MUSCULAR DYSTROPHY; EXON; GENE MUTATION; GENE THERAPY; HISTORY OF MEDICINE; HUMAN; MEDICAL RESEARCH; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; REVIEW; RNA SPLICING;

EID: 0030152856     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/0387-7604(96)00007-1     Document Type: Review

References (38)

1. 1. Emery AEH. Duchenne muscular dystrophy. Oxford: Oxford University Press, 1993: 392.
2. 2. Matsuo M, Masumura T, Nishio H, et al. Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy Kobe. J Clin Invest 1991; 87: 2127-31.
3. 3. Hoffman EP, Kunkel LM. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron 1989; 2: 1019-29.
4. 4. Rojas C, Hoffman E. Recent advances in dystrophin research. Curr Opin Neurobiol 1991; 1: 420-29.
5. 5. Hoffman E, Brown R, Kunkel L. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919-28.
6. 6. Burghes AHM, Logan C, Hu X, et al. A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature 1987; 328: 434-7.
7. 7. Nishio H, Takeshima Y, Narita N, et al. Identification of a novel first exon in the human dystrophin gene and of a new promoter locatedmore than 500 kb upstream of the nearest known promoter. J Clin Invest 1994; 94: 1037-42.
8. 8. Yamamoto H, Hagiwara Y, Mizuno Y, Yoshida M, Ozawa, E. Heterogeneity of dystrophin-associated proteins. J Biochem 1993; 114: 132-9.
9. 9. Matsumura K, Tome F, Collin H, et al. Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature 1992; 359: 320-2.
10. 10. Piccolo F, Roberds SL, Jeanpierre M, et al. Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat Genet 1995; 10: 243-5.
11. 11. Ahn AH, Kunkel LM. The structural and functional diversity of dystrophin. Nat Genet 1993; 3: 283-91.
12. 12. D'Souza VN, thi Man N, Morris GE, et al. A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet 1995; 4: 837-42.
13. 13. Koenig M, Hoffman EP, Bertelson CJ, et al. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987; 50: 509-17.
14. 14. Hu X, Ray P, Murphy E, Thompson M, Worton R. Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotype genotype correlation. Am J Hum Genet 1990; 46: 682-95.
15. 15. Monaco AP, Bertelson C, Liechti-Gallati S, Moser H, Kunkel L. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988; 2: 90-5.
16. 16. Gillard EF, Chamberlain JS, Murphy EG, et al. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet 1989; 45: 507-20.
17. 17. Arahata K, Ishiura S, Ishiguro T, et al. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 1988; 333: 861-3.
18. 18. Hoffman EP, Fischbeck KH, Brown RH, et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 1988; 318: 1363-8.
19. 19. Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990; 86: 45-8.
20. 20. Ishigaki C, Patria SY, Nishio H, Yabe M, Matsuo M. A Japanese boy with myalgia and cramps and a novel in-frame deletion of the dystrophin gene. Neurology, in press.
21. 21. Kitoh Y, Matsuo M, Nishio H, et al. Amplification of ten deletion-rich exons of the dystrophin gene by polymerase chain reaction shows deletions in 36 of 90 Japanese patients with Duchenne muscular dystrophy. Am J Med Genet 1992; 42: 453-7.
22. 22. Cutiongco EM, Padilla CD, Takenaka K, et al. More deletions in the 5′ region than in the central region of the dystrophin gene were identified among Filipino Duchenne and Becker muscular dystrophy patients. Am J Med Genet, 1995 59: 266-7.
23. 23. Gardner RJ, Bobrow M, Roberts RG. The identification of point mutations in Duchenne muscular dystrophy patients by using reverse-transcription PCR and the protein truncation test. Am J Hum Genet 1995; 57: 311-20.
24. 24. Hogervorest FBL, Cornelis RS, Bout N, et al. Rapid detection of BRCA1 mutations by the protein truncated test. Nature Genet 1995; 10: 208-12.
25. 25. Roberts RG, Gardner RJ. Bobrow M. Searching for the 1 in 2,400,000: a review of dystrophin gne point mutations. Hum Mutat 1994; 4: 1-11.
26. -1 to T) in a 5′ splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy. Am J Hum Genet 1994; 54: 53-61.
27. 27. Acsadi G, Dickson G, Love D, et al. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 1991: 352: 815-18.
28. 28. Wells D, Wells K, Walsh F, et al. Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice. Hum Mol Genet 1992; 1: 35-40.
29. 29. Cox G, Phelps S, Chapman V, Chamberlain J. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nat Genet 1993; 4: 87-93.
30. 30. Dunckley M, Wells D, Walsh F, Dickson G. Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum Mol Genet 1993; 2: 717-23.
31. 31. Ragot T, Vincent N, Chafey P, et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 1993; 361: 647-50.
32. 32. Vincent N, Ragot T, Gilgenkrantz H, et al. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat Genet 1993: 5: 130-4.
33. 33. Green MR. Pre-mRNA splicing. Annu Rev Genet 1986; 20: 671-708.
34. 34. Matsuo M, Masumura T, Nakajima T, et al. A very small frame-shifting deletion within exon 19 of the Duchenne muscular dystrophy gene. Biochem Biophys Res Commun 1990; 170: 963-7.
35. 35. Takeshima Y, Nishio H, Sakamoto H, Nakamura H, Matsuo M. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe. J Clin Invest 1995: 95: 515-20.
36. 36. Tanaka K, Watakabe A, Shimura Y. Polypurine sequences within a downstream exon function as a splicing enhancer. Mol Cell Biol 1994; 14: 1347-54.
37. 37. Barabino SML, Sproat BS, Lamond AI. Antisense probes targeted to an internal domain in U2 snRNP specifically inhibit the second step of pre-mRNA splicing. Nucleic Acids Res 1992; 20: 4457-64.
38. 38. Dominski Z, Kole R. Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc Natl Acad Sci USA 1993; 90: 8673-7.